188 related articles for article (PubMed ID: 22531341)
1. Laboratory identification of factor inhibitors: an update.
Kershaw G; Favaloro EJ
Pathology; 2012 Jun; 44(4):293-302. PubMed ID: 22531341
[TBL] [Abstract][Full Text] [Related]
2. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
Kershaw G; Jayakodi D; Dunkley S
Semin Thromb Hemost; 2009 Nov; 35(8):760-8. PubMed ID: 20169512
[TBL] [Abstract][Full Text] [Related]
3. Recent improvements in the clinical treatment of coagulation factor inhibitors.
Franchini M; Lippi G
Semin Thromb Hemost; 2009 Nov; 35(8):806-13. PubMed ID: 20169517
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII inhibitors. Laboratory diagnosis of inhibitors.
Sahud MA
Semin Thromb Hemost; 2000; 26(2):195-203. PubMed ID: 10919413
[TBL] [Abstract][Full Text] [Related]
5. Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors.
Favaloro EJ; Bonar R; Kershaw G; Duncan E; Sioufi J; Marsden K
Semin Thromb Hemost; 2009 Nov; 35(8):794-805. PubMed ID: 20169516
[TBL] [Abstract][Full Text] [Related]
6. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
Buchanan GR; Kevy SV
Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
[TBL] [Abstract][Full Text] [Related]
8. Clinicohaematological profile of two cases of inhibitors to factor VIII.
Shanthala Devi AM; Srikrishna A; Sitalaksmi S; Damodar P
Indian J Pathol Microbiol; 2001 Jul; 44(3):365-6. PubMed ID: 12024937
[TBL] [Abstract][Full Text] [Related]
9. Improvements in factor VIII inhibitor detection: From Bethesda to Nijmegen.
Verbruggen B; van Heerde WL; Laros-van Gorkom BA
Semin Thromb Hemost; 2009 Nov; 35(8):752-9. PubMed ID: 20169511
[TBL] [Abstract][Full Text] [Related]
10. [Acquired haemophilia A].
Brouwer RE; Huisman MV; Feuth JD; van der Meer FJ
Ned Tijdschr Geneeskd; 1997 Jul; 141(27):1342-4. PubMed ID: 9380188
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors in mild/moderate haemophilia A: an update.
Franchini M; Salvagno GL; Lippi G
Thromb Haemost; 2006 Aug; 96(2):113-8. PubMed ID: 16894451
[TBL] [Abstract][Full Text] [Related]
12. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
Gadarowski JJ; Czapek EE; Ontiveros JD; Pedraza JL
Acta Haematol; 1988; 80(3):134-8. PubMed ID: 3143212
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and quantification of factor VIII inhibitors.
Verbruggen B
Haemophilia; 2010 May; 16(102):20-4. PubMed ID: 19228204
[TBL] [Abstract][Full Text] [Related]
14. [Clinical cases of acquired coagulation inhibitors].
Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
[TBL] [Abstract][Full Text] [Related]
15. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
Blanco AN; Cardozo MA; Candela M; Santarelli MT; Pérez Bianco R; Lazzari MA
Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638
[TBL] [Abstract][Full Text] [Related]
16. Laboratory identification of factor VIII inhibitors in the real world: the experience from Australasia.
Favaloro EJ; Bonar R; Kershaw G; Mohammed S; Duncan E; Marsden K;
Haemophilia; 2010 Jul; 16(4):662-70. PubMed ID: 20070382
[TBL] [Abstract][Full Text] [Related]
17. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor].
Komiyama Y; Munakata M; Masuda M; Kagawa H; Fukuhara S; Takahashi H
Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors in congenital coagulation disorders.
Key NS
Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
[TBL] [Abstract][Full Text] [Related]
19. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
Chng WJ; Sum C; Kuperan P
Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
[TBL] [Abstract][Full Text] [Related]
20. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).
Hay CR; Baglin TP; Collins PW; Hill FG; Keeling DM
Br J Haematol; 2000 Oct; 111(1):78-90. PubMed ID: 11091185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
